ZBNA
JAZZ icon

Zions Bancorporation, National Association’s Jazz Pharmaceuticals JAZZ Stock Holding History

Zions Bancorporation, National Association’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.68K Buy
36
+12
+50% +$2.63K ﹤0.01% 944
2026
Q1 		$4.54K Buy
24
+17
+243% +$2.97K ﹤0.01% 1022
2025
Q4 		$1.19K Buy
+7
New +$1.07K ﹤0.01% 1064

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Zions Bancorporation, National Association's JAZZ Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Jazz Pharmaceuticals (JAZZ) stake by 50% in Q2 2026, buying an estimated $2.63K and bringing the position to 36 shares worth $8.68K. The position accounts for ﹤0.01% of the portfolio, ranked #944.

Zions Bancorporation, National Association first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 303 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Zions Bancorporation, National Association held 36 shares of Jazz Pharmaceuticals worth $8.68K as of Q2 2026.
  • Zions Bancorporation, National Association bought 12 Jazz Pharmaceuticals shares in Q2 2026, an estimated $2.63K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #944 holding.
  • Zions Bancorporation, National Association first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.